Bonnie Bermas provides an independent viewpoint on the results of a study suggesting that the use of biologic agents by women with rheumatoid arthritis during pregnancy is not associated with an increased serious infection risk for their babies.
09-11-2017 | ACR/ARHP 2017 | Video